Google DeepMind Launches AlphaGenome 2 to Decode Genetic Variant Impact

Google DeepMind unveiled AlphaGenome 2, an AI model linking single-cell biology with human genetics to predict disease-related variant effects across hundreds of cell types. The model's capabilities could accelerate genomic medicine, though clinical validation and integration into healthcare remain uncertain. This marks a notable advance in AI-driven genomics, potentially reshaping drug discovery and diagnostics.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works